National Cancer Institute; Amended Notice of Meeting, 71437 [2019-27854]

Download as PDF Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices Contact Person: Melissa E Nagelin, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 20892, 301–435–0297, nagelinmh2@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research. Date: February 20, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review Officer, Division of Extramural Activities, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Rockville, MD 20892, zhihong.shan@nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Circadian Patterns of Gene Expression Associated with Disease. Date: February 28, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review Officer, Division of Extramural Activities, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Rockville, MD 20892, zhihong.shan@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: December 19, 2019. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–27856 Filed 12–26–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSKJLSW7X2PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(D) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Science Advisory Board for Biosecurity. The meeting will be open to the public, with attendance limited to space available. The meeting will also be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). Individuals planning to attend in person may preregister online at: https:// VerDate Sep<11>2014 18:44 Dec 26, 2019 Jkt 250001 osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/. Preregistration will close at 12:00 noon Eastern Time (ET) on January 17, 2020. Individuals in attendance may also register onsite on the day of the meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Science Advisory Board for Biosecurity. Date: January 23–24, 2020. Time: January 23, 2020, 12:30 p.m. to 5:00 p.m. (ET). Agenda: The National Science Advisory Board for Biosecurity will discuss: (1) Considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; (2) other business of the Board; and (3) a charge to the committee will be presented. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814. Time: January 24, 2020, 9:00 a.m. (ET) to Adjournment. Agenda: The National Science Advisory Board for Biosecurity will discuss: (1) Considerations regarding security and public transparency when sharing information about research involving enhanced potential pandemic pathogens; and (2) other business of the Board. Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Shayla Beckham, Management Program Analyst, Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892–9606, 301–496–9838, shayla.beckham@nih.gov. Any interested person may file written comments by forwarding the statement to the Contact Person listed on this notice. Additional information about the meeting, including an agenda, will be posted at: https://osp.od.nih.gov/biotechnology/ national-science-advisory-board-forbiosecurity-nsabb/ when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: December 19, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–27862 Filed 12–26–19; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 71437 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel Transition to Independence SEP, March 10, 2020, 10:30 a.m. to 5:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W602, Rockville, MD 20850 (Telephone Conference Call) which was published in the Federal Register on December 16, 2019, 84 FR 68465. This meeting notice is amended to correct the meeting name from National Cancer Institute Special Emphasis Panel Transition to Independence SEP to National Cancer Institute Initial Review Group Transition to Independence. The meeting is closed to the public. Dated: December 19, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–27854 Filed 12–26–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; Clinical Trials Review Committee. Date: February 27–28, 2020. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn, Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Keary A. Cope, Ph.D., Scientific Review Officer, Office of Scientific E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Page 71437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27854]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel Transition to Independence SEP, 
March 10, 2020, 10:30 a.m. to 5:00 p.m., National Cancer Institute 
Shady Grove, 9609 Medical Center Drive, Room 7W602, Rockville, MD 20850 
(Telephone Conference Call) which was published in the Federal Register 
on December 16, 2019, 84 FR 68465.
    This meeting notice is amended to correct the meeting name from 
National Cancer Institute Special Emphasis Panel Transition to 
Independence SEP to National Cancer Institute Initial Review Group 
Transition to Independence. The meeting is closed to the public.

    Dated: December 19, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27854 Filed 12-26-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.